Lv1
70 积分 2025-08-18 加入
Enzyme-Agnostic Lysosomal Screen Identifies New Legumain-Cleavable ADC Linkers
2天前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
1个月前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
2个月前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
2个月前
已完结
Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
2个月前
已完结
Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation
5个月前
已完结
Bispecific Nanobody‐Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors
5个月前
已完结
Bispecific Aptamer Chimeras Enable Targeted Protein Degradation on Cell Membranes
5个月前
已完结
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
7个月前
已完结
Bispecific Aptamer-Based Recognition-then-Conjugation Strategy for PD1/PDL1 Axis Blockade and Enhanced Immunotherapy
7个月前
已完结
皖公网安备34019202002308
